Granules India Q2 Revenue Jumps 34% YoY; Profit Climbs to ₹1,306 Million

Hyderabad, November 13: Granules India Ltd (NSE: GRANULES | BSE: 532482) reported a strong performance for the quarter ended September 30, 2025, posting a 34% year-on-year growth in revenue. The company’s net profit stood at ₹1,306 million, supported by robust demand and favourable market conditions. Following the results announcement, Granules India shares gained over 2%, reflecting investor optimism about the company’s growth momentum.

Q2 FY26 Performance Overview

Granules India Ltd posted revenue from operations of ₹12,969.88 million in Q2 FY26, up significantly from ₹9,666.19 million in Q2 FY25, reflecting a 34.1% year-on-year increase. Sequentially, revenue also rose from ₹9,666.19 million in the previous quarter. Total income grew to ₹12,958.39 million from ₹9,698.74 million a year ago.

The strong top-line performance translated into higher profitability. Profit Before Tax (PBT) surged to ₹1,758.65 million from ₹972.34 million in Q2 FY25, while net profit climbed to ₹1,306.06 million, up 34.3% year-on-year from ₹972.34 million and higher than ₹1,126.36 million in the previous quarter. This growth underscores the company’s solid operational performance and strong market response.

Half-Year (H1 FY26) Performance

The first half of FY26, ending September 30, 2025, saw Granules India Ltd generate a total income of ₹25,222.90 million, up from ₹21,518.03 million in H1 FY25. Revenue from operations rose to ₹25,070.94 million from ₹21,464.84 million in the corresponding period last year.

The growth in income positively impacted profitability, with net profit reaching ₹2,432.42 million, up from ₹2,318.82 million year-on-year, reflecting the company’s strong operational performance and consistent market demand.

Market Reaction

The share price of Granules India Limited closed at ₹554.05 as of November 13, 2025. This is a 2.14% or ₹11.60 rise from its previous close of ₹542.45. The intraday range was between ₹536.20 and ₹561.80. The company has had a positive trading session so far. Its total market capitalisation stood at ₹13,445.06 crore. Further, it had a total traded value and volume of ₹144.77 crore and 26.20 lakh shares, respectively.

Granules India Ltd is a Hyderabad-based pharmaceutical manufacturer. It specialises in APIs, PFIs, and finished dosages. The company operates across multiple global markets. It has a strong presence in regulated regions. It has been listed since 2005 on NSE and BSE and trades under the tickers GRANULES and 532482, respectively. It is part of the NIFTY Smallcap 250 index.

REF: https://nsearchives.nseindia.com/corporate/GRANULES_13112025133112_NSEBSEFINANCIALOUTCOME.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations